Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

NeuroproteXeon

NeuroproteXeon
2014 FOUNDED
PRIVATE STATUS
Bankr. Admin/Reorg LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Provider of late clinical-stage pharmaceutical and medical devices.. The company's inhalation device protects against brain cell death following acute neurologic injury.

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Therapeutic Devices
Primary Office
  • 50 Cobham Drive
  • Orchard Park
  • New York, NY 14127
  • United States

+1 (716) 000-0000

NeuroproteXeon Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore NeuroproteXeon‘s full profile, request access.

Request full access to PitchBook

NeuroproteXeon Executive Team (6)

Name Title Board
Seat
Contact
Info
Bill Burns Chief Executive Officer & Director
Jim McAuliffe Chief Financial Officer & Director
Matt Napoletano Chief Operating Officer & Director
Michelle Cullen Chief Accounting Officer
Mervyn Maze Co-Founder
You’re viewing 5 of 6 executives. Get the full list »